The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlus500 Regulatory News (PLUS)

Share Price Information for Plus500 (PLUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,154.00
Bid: 2,160.00
Ask: 2,162.00
Change: -8.00 (-0.37%)
Spread: 2.00 (0.093%)
Open: 2,140.00
High: 2,174.00
Low: 2,140.00
Prev. Close: 2,162.00
PLUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of EGM

11 Feb 2020 16:33

RNS Number : 6775C
Plus500 Limited
11 February 2020
 

11 February 2020

 

Plus500 Ltd.

 

("Plus500" or "the Company")

 

Notice of EGM

 

Plus500, a leading online service provider for trading Contracts for Difference ("CFDs") internationally, announces that following its announcement of 16 January 2020 regarding its Extraordinary General Meeting to be held at 4.30pm on 20 February 2020 ("EGM"), for the purpose of approving the remuneration arrangements for its executive directors for the year ending 31 December 2020 as the Company is required to do under Israeli Law, the Company hereby advises that an updated Notice of EGM is available for review at https://www.plus500.co.uk/Investors/CompanyAnnouncements, reflecting changes to the proposed remuneration arrangements for the executive directors following consultation with shareholder bodies.

 

The EGM will be held at the offices of MHP Communications, 6 Agar Street, London, WC2N 4HN. There is no change to the date of the EGM, the record date of shareholders entitled to vote at the EGM or the deadline for submission of a Form of Proxy and Form of Direction, as applicable, as set forth in the notes to the Notice of EGM.

 

An updated Form of Proxy and an updated Form of Direction are also available at https://www.plus500.co.uk/Investors/CompanyAnnouncements. Shareholders and Depositary Interests holders ("DI Holders") may vote either by printing the updated Form of Proxy or updated Form of Direction, as applicable, or by submitting the original Form of Proxy or Form of Direction received. Shareholders and DI holders that submitted a Form of Proxy or Form of Direction, as applicable, prior to the date hereof may replace their prior vote or elect not to change their vote and not take any further action, in which case the original Form of Proxy or Form of Direction submitted shall be counted for purposes of their vote.

 

To be valid, any Form of Proxy or other instrument appointing a proxy and any power of attorney or other authority under which it is signed, or a notarially certified or office copy of such power or authority, must be received by post or (during normal business hours only) by hand at (i) Link Market Services Limited, Proxies, The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU or (ii) Plus500, Investor Relations, Matam, Building 25, Haifa 3190500, Israel (or by email to ir@plus500.com), by no later than 4.30 p.m. on 17 February 2020.

 

In the case of DI holders, a Form of Direction must be completed in order to appoint the Depository whose registered office is at The Registry, 34 Beckenham Road, Beckenham, Kent, BR3 4TU to vote on the holder's behalf at the meeting. To be effective, a completed and signed Form of Direction must be deposited at Link Market Services Limited no later than 4.30 p.m. on 14 February 2020.

 

In compliance with LR 9.6.1, the Updated Notice of EGM has been submitted to the National Storage Mechanism as submission to the Financial Conduct Authority and will shortly be available for inspection at: www.morningstar.co.uk/UK/NSM.

 

 

For further details:

 

Plus500 Ltd

Elad Even-Chen, Chief Financial Officer

ir@Plus500.com

 

Tel: +972-4 8189503

 

MHP Communications

Reg Hoare, Rachel Mann, Pete Lambie

plus500@mhpc.com

 

 

Tel: 020 3128 8100

 

About Plus500

 

Plus500 operates an online trading platform for individual customers to trade CFDs internationally. The Group offers more than 2,800 different underlying global financial instruments, comprising equities, indices, commodities, options, ETFs, foreign exchange and cryptocurrencies. Individual customers of Plus500 can trade CFDs in more than 50 countries and in 32 languages. The trading platform is accessible from multiple operating systems (Windows, smartphones (iOS, Android and Windows Phone), tablets (iOS, Android and Surface) and web browsers). Plus500 retains operating licences and is regulated in the United Kingdom, Australia, Cyprus, Israel, New Zealand, South Africa, Singapore and the Seychelles. Customer care is integral to Plus500: customers cannot be subject to negative balances. Plus500 does not utilise cold calling techniques and does not offer binary options. A free demo account is available on an unlimited basis for platform users, and sophisticated risk management tools are provided free of charge to manage leveraged exposure, and stop losses to help customers protect profits and limit capital losses. Plus500 is listed on the main market of the London Stock Exchange, under the symbol PLUS.www.plus500.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFLFVRFIILLII
Date   Source Headline
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSQ1 2024 Trading Update
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNS2023 Annual Report and 2024 Annual General Meeting
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSShare Buyback Programme Announcement
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:03 amRNSFY 2023 Preliminary Results
20th Feb 20247:01 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.